Matthew Hall
0000-0002-5073-442X
National Center for Advancing Translational Sciences
9 papers found
Refreshing results…
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors
Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Discovery and Structure–Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
Missing publications? Search for publications with a matching author name.